Australia and New Zealand - Press Releases

New Collections, Refined Craftsmanship, and an Outdoor-Focused Oasis That Supports Every Moment in Senior Living

BOSTON, April 30, 2025 /PRNewswire/ -- VOTF, a Catholic Lay Apostolate committed to promoting transparency in Church operations, has published its 2024 diocesan financial and governance transparency reports. Before being publicly released, the reports were sent to each diocesan bishop and to CFOs of each of the 176 dioceses in the USCCB. The average overall 2024 transparency score remained unchanged from 71% in 2023 to 71% in 2024. The overall governance score increased from 34% in 2023 to 35% in 2024. The 2024 reports and all previous VOTF reports on diocesan financial and governance transparency may be found on the VOTF website clicking here.

HOPE Homes - A 27-Unit Modular Casita Community Made Possible Under New SB4

NEW YORK, April 30, 2025 /PRNewswire/ -- On April 26, 2025, Babymint, a next-generation peer-to-peer marketplace dedicated to secondhand baby and kids' products, hosted its inaugural Earth Month Shopping Event in New York City - and parents showed up in full force to champion a more sustainable future.

1,500 summer learning curriculum kits will benefit students across the state this summer.

FORT LAUDERDALE, Fla., April 30, 2025 /PRNewswire/ -- For National Financial Literacy Month Consolidated Credit celebrated community partners who bring financial education to life. At its 11th Annual Financial Literacy Month Breakfast, held at JA World in Coconut Creek, FL on Friday, April 18, 2025, leaders across South Florida gathered to recognize the organizations and individuals who are shaping a more financially secure future.

FORT LAUDERDALE, Fla., 30 de abril de 2025 /PRNewswire-HISPANIC PR WIRE/ -- Para el Mes Nacional de la Educacin Financiera, Consolidated Credit celebr a los socios de la comunidad que dan vida a la educacin financiera. En su 11 Desayuno Anual del Mes de la Educacin Financiera, celebrado en JA World en Coconut Creek, Florida, el viernes 18 de abril de 2025, los lderes del sur de Florida se reunieron para reconocer a las organizaciones e individuos que estn dando forma a un futuro ms seguro financieramente.

IRVINE, Calif., May 1, 2025 /PRNewswire/ -- Kia America delivered 74,805 total units in April, up 14-percent over the same period last year, achieving the highest-ever sales figure for the month of April. This record has extended Kia's record-breaking sales streak to seven months and the retail sales at Kia dealerships increasedby 24-percent over April 2024, reinforcing the company's strong growth trajectory in the marketplace.

More than half of Aging Life Care Managers' clients are living with dementia, a new national survey finds.

Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include treatment for diabetic macular edema, the primary cause of blindness related to diabetes. This marks the second approved indication for Susvimo, which was initially cleared in October 2021 as an alternative to frequent eye injections for wet age-related macular degeneration.

PLAINSBORO, N.J., April 30, 2025 /PRNewswire/ -- Today, The New England Journal of Medicine(NEJM) published results from part 1 of the ongoing phase 3 ESSENCE trial which investigated the effects of once-weekly subcutaneous semaglutide 2.4 mg on liver histology compared to placebo at 72 weeks in adults with MASH and moderate to advanced liver fibrosis (stage 2 or 3). At Week 72, the first primary endpoint showed 62.9% of people treated with semaglutide 2.4 mg achieved resolution of steatohepatitis with no worsening of liver fibrosis compared to 34.3% on placebo with estimated difference in responder proportions (EDP) of 28.7% (95% CI, 21.1 to 36.2; P<0.001). For the second primary endpoint at Week 72, 36.8% of people treated with semaglutide 2.4 mg achieved improvement in liver fibrosis with no worsening of steatohepatitis compared to 22.4% on placebo (EDP, 14.4%; 95% CI, 7.5 to 21.3; P<0.001).1

CALGARY, AB, April 30, 2025 /PRNewswire/ -Willow Biosciences Inc. (the "Company") (TSX:WLLW) (OTCQB: CANSF) announces the completion today of the sale (the "Transaction") of its wholly-owned operating subsidiary, Epimeron USA, Inc., to the U.S. subsidiary of Mycofeast Ltd., a privately-held, arms-length entity based in the United Kingdom (the "Purchaser"), pursuant to the terms of a share purchase agreement dated March 14, 2025 (the "Share Purchase Agreement"), between the Company and the Purchaser.

FREDERICK, Md., April 30, 2025 /PRNewswire/ -- RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services, today announced a new collaboration with Thermo Fisher Scientific, the world leader in serving science. This collaboration aims to accelerate the availability of new, potentially life-saving cell and exosome therapies that have the potential to revolutionize the treatment of degenerative disease.

YMCA Launches Interactive Teen Mental Health Resource Hub for Mental Health Awareness Month

PALMETTO, Fla., April 30, 2025 /PRNewswire/ -- BayCare, the leading health care system in West Central Florida, broke ground today on BayCare Hospital Manatee, its 17th hospital, and BayCare HealthHub(Manatee). This milestone marks a significant step in expanding access to health care for the growing Manatee County community. The hospital will be the county's first not-for-profit hospital and the only hospital north of the Manatee River.

MEXICO CITY, April 30, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.

DURHAM, N.C., April 30, 2025 /PRNewswire/ --Satsuma Pharmaceuticals, Inc., a late-stage biopharmaceutical company dedicated to bringing novel treatments to people who suffer from migraine and other debilitating conditions, and its corporate parent, Shin Nippon Biomedical Laboratories, Ltd. (TSE:2395), today announced that the U.S. Food and Drug Administration (FDA) has approved a 505(b)(2) New Drug Application (NDA) for Atzumi(dihydroergotamine (DHE)) nasal powder for the acute treatment of migraine with or without aura in adults. Atzumi was previously known as STS101.

Experten der Pharmaindustrie kommen zusammen, um die Zukunft der KI mitzugestalten

Blue Earth Therapeutics (PRNewsfoto/Blue Earth Therapeutics Ltd)

SEOUL, South Korea, May 1, 2025 /PRNewswire/ -- S&E bio Co., Ltd., a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of Food and Drug Safety (MFDS) to initiate a Phase 1b clinical trial of its investigational stroke therapy, SNE-101. This is the first exosome-based therapy in Korea to enter clinical trials, marking a major milestone in the country's biopharmaceutical landscape.

The national non-profit organization recognizes how superhero moms like Chelsea Noble Cameron shape generations, recognizing birth moms, adoptive moms and foster moms.

The industry veteran brings over 25 years of healthcare marketing expertise in accelerating growth and value for leading pharmaceutical brands

INDIANAPOLIS, April 30, 2025 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced its Board of Directors has authorized a common stock dividend of $0.17 cents per share, payable June 16, 2025, to the Company's shareholders of record on June 2, 2025.

Strong Quarter-to-Quarter Margin Progression

GROTON, Conn., April 30, 2025 /PRNewswire/ --General Dynamics Electric Boat, a business unit of General Dynamics (NYSE: GD), announced today it has been awarded a total of $12.4 billion in contract modifications for construction of two fiscal year 2024 Virginia-class submarines. Additionally, the award funds investments to improve productivity at the shipyards and workforce support as detailed in the Department of Defense contract awardannouncement (https://www.defense.gov/News/Contracts/Contract/Article/4170827/).This contract includes options which, if exercised, would bring the cumulative value to $17.2 billion.